Sectoral Asset Management Inc. grew its position in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) by 235.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 201,000 shares of the company’s stock after purchasing an additional 141,000 shares during the period. Sectoral […]
Sectoral Asset Management Inc. increased its stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) by 235.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 201,000 shares of the company’s stock after purchasing an additional 141,000 shares during the quarter. Sectoral Asset […]
Zentalis Pharmaceuticals (NASDAQ:ZNTL – Get Rating) had its price target cut by equities research analysts at Jefferies Financial Group from $120.00 to $70.00 in a research report issued to clients and investors on Friday, The Fly reports. Jefferies Financial Group’s price objective points to a potential upside of 162.27% from the stock’s current price. A […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) – Investment analysts at HC Wainwright decreased their Q2 2023 earnings per share estimates for shares of Zentalis Pharmaceuticals in a research note issued to investors on Thursday, May 11th. HC Wainwright analyst A. Fein now expects that the company will earn ($1.15) per share for the quarter, […]
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) shares were down 4.9% during mid-day trading on Monday . The stock traded as low as $21.17 and last traded at $21.20. Approximately 62,734 shares traded hands during trading, a decline of 89% from the average daily volume of 588,935 shares. The stock had previously closed at $22.29. […]